Related Experiment Video
Updated: Nov 30, 2025

11:43
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Published on: November 30, 2016
13.2K
Transient commensal clonal interactions can drive tumor metastasis.
Suha Naffar-Abu Amara1, Hendrik J Kuiken1, Laura M Selfors1
1Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA.
Nature Communications
|November 17, 2020
Summary
Transient, non-tumorigenic ovarian cancer cells can promote metastasis through "hit-and-run" interactions. These findings reveal a novel mechanism of tumor cell cooperation in promoting cancer spread.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Functional heterogeneity and crosstalk among tumor cells are critical but poorly understood aspects of cancer progression.
- Ovarian clear cell carcinoma (OCCC) models are essential for studying metastasis, particularly the formation of ascites and peritoneal tumors.
Purpose of the Study:
- To investigate the role of functional heterogeneity and interclonal interactions in promoting metastasis of OCCC.
- To elucidate the mechanisms by which transient tumor subpopulations contribute to metastatic dissemination.
Main Methods:
- Generation of clonal OCCC populations from a patient-derived model.
- Engineering clones with Gaussia luciferase for growth monitoring and DNA barcodes for fate tracking.
- Intraperitoneal transplantation of clonal and multiclonal mixtures in mice to study tumor progression and metastasis.
Main Results:
- A single clone, CL31, robustly formed ascites but not solid tumors in clonal settings.
- Multiclonal mixtures led to extensive solid peritoneal metastases, primarily composed of CL31.
- CL31's metastatic potential in mixtures was dependent on amphiregulin secreted by non-tumorigenic clones, facilitating mesothelial clearance.
Conclusions:
- Transient, non-tumorigenic tumor subpopulations can act as commensals, promoting metastasis of other clones via a
- hit-and-run
- mechanism.
- Interactions between distinct tumor cell subpopulations play a crucial role in overcoming metastatic barriers.
More Related Videos
Related Concept Videos
Metastasis
6.1K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.1K
The Tumor Microenvironment
7.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
Tumor Progression
7.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
Cancer Stem Cells and Tumor Maintenance
5.5K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.5K
Adaptive Mechanisms in Cancer Cells
6.4K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.4K
T Cell Activation and Clonal Selection
14.2K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.2K

